Celgene Senior Manager, Project Management - Translational Development and Precision Medicine in Summit, New Jersey


Celgene is a global biopharmaceutical company leading the way in medical innovation to help patients live longer, better lives. Our purpose as a company is to discover and develop therapies that will change the course of human health. We value our passion for patients, ​quest for innovation, spirit of independence and love of challenge. With a presence in more than 70 countries, and growing - we look for talented people to grow our business, advance our science and contribute to our unique culture.

Translational Development at Celgene

Translational Development is part of the Global Research and Early Development organization in Celgene and leads early stage clinical, pharmacological and translational research and development activities for the pipeline and supports late stage portfolio for regulatory, translational development and life cycle management. Within Translational Development exists a precision medicine and companion diagnostics group to support multiple disease areas of interest including Myeloma, Lymphoma, MDS/AML and other hematological malignancies as well as inflammatory disease programs.

This group will integrate scientific and business insights of multiple functions to provide innovative translational programs and patient centric solutions that will make precision medicine a reality for the patients and physicians we serve. This department (or function) will be responsible for leading the development of translational, precision medicine and companion diagnostics programs across the Celgene organization.

The Senior Manager, Project Management, reports to the Director, Project Management – Translational Development, Precision Medicine & Companion Diagnostics (TD/PM/CDx). He/she is accountable, with the TD/PM/CDx Project Lead to support Celgene’s Global Project Teams and Disease Strategy Teams, as applicable, to successfully shape and execute the various translational and diagnostic strategies, projects, and lifecycle plans.

Roles and responsibilities include, but are not limited to, the following:

  • Responsibilities may vary based on project and stages of development (early, late, and lifecycle)

  • Manage the implementation of TD/PM/CDx projects of low to medium complexity to support global project teams and/or disease teams, as applicable

  • Responsible for managing the TD/PM/CDx project team and deliverables, working effectively with cross-functional representatives including scientific, clinical, regulatory, legal, finance

  • Responsible for developing and coordinating resource planning across functions to assure that adequate resources are being applied to the project

  • Develop and maintain timelines for TD/PM/CDx activities, assure alignment with global project timelines as applicable, update timeline on an ongoing basis to allow transparency to the organization

  • Prepare and track project budgets, manage project financials including accruals and payables, work with legal and the TD/PM/CDx Project Lead to develop contracts for research collaborators and service providers

  • Identify project risks with the project team, drive for resolution of project issues

  • Prepare regular progress reports and ad hoc reports to facilitate seamless communication and transparency of project status throughout the organization

  • Establish a close partnering relationship with the Global Project Leader and Global Project Manager, for applicable drug development projects

  • Establish a close working relationship with external development partners, collaborators, and specialty contract research providers to monitor the execution of TD/PM/CDx projects

  • Ensure that team recommendations related to project direction in need of endorsement by Decision Committees are planned for review by the Committees and updates on projects are planned with Decision Committees

  • Partner with Project Management Operations to implement best practices for project managers of TD/PM/CDx teams, e.g., resource capacity planning, project risk management, team performance, and timeline development

  • Assure that the Celgene values are demonstrated in all aspects of the team work

Skills/Knowledge Required:

  • Bachelor’s degree with a minimum 5 years of pharma or medical device experience, 2 years project management experience or equivalent; PMP certification desirable.

  • Knowledge of the drug development, medical device, and/or translational development processes, and supportive project management processes

  • Strong project management skills, outcomes oriented, and results driven

  • Demonstrates effective communication skills, cross-functional collaboration skills, and a cross-cultural awareness

  • Works with a moderate level of independence to lead projects and teams

  • Ability to effectively manage conflicts and negotiations, and influence outcomes without direct authority

  • Excellent organizational, analytical, and planning skills

  • Knowledge of the project financial budgeting and expenditures process, and contracts development process

  • Effectively utilize project management tools and information technology systems such as Microsoft Office, Project, Excel, Visio, etc


Celgene is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status. Celgene complies with all applicable national, state and local laws governing nondiscrimination in employment as well as employment eligibility verification requirements of the Immigration and Nationality Act. All applicants must have authorization to work for Celgene in the U.S.COMMITTED TO IMPROVING THE LIVES OF PATIENTS WORLDWIDE

At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients. Our vision as a company is to build a major global biopharmaceutical corporation while focusing on the discovery, the development, and the commercialization of products for the treatment of cancer and other severe, immune, inflammatory conditions.

“At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients.”

There are more than 300 clinical trials at major medical centers using compounds from Celgene. Investigational compounds are being studied for patients with incurable hematological and solid tumor cancers, including multiple myeloma, myelodysplastic syndromes, chronic lymphocytic leukemia (CLL), non-Hodgkin’s lymphoma (NHL), triple-negative breast cancer and pancreatic cancer. As committed as we are to clinical accomplishment, we are equally committed to patient support, which is a guiding principle at Celgene. We believe all who can benefit from our discoveries should have the opportunity to do so. Celgene puts patients first with industry-leading programs that provide information, support and access to our innovative therapies.